Motus GI (MOTS) Stock Price, News & Analysis

Company Overview

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 700 shs
• Average Volume: 5,050 shs
• Market Capitalization: $1 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Motus GI Stock Analysis - MarketRank™

Motus GI scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Motus GI.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Motus GI is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Motus GI is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.11% of the float of Motus GI has been sold short.

Short Interest Ratio / Days to Cover

Motus GI has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Motus GI does not currently pay a dividend.

Dividend Growth

Motus GI does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.11% of the float of Motus GI has been sold short.

Short Interest Ratio / Days to Cover

Motus GI has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

News and Social Media

• Score: 1.1 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for MOTS on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Motus GI to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Motus GI insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.34% of the stock of Motus GI is held by insiders.

Percentage Held by Institutions

Only 20.06% of the stock of Motus GI is held by institutions.

MOTS Stock Analysis - Frequently Asked Questions

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) released its earnings results on Friday, November, 12th. The company reported ($30.00) EPS for the quarter, hitting the consensus estimate of ($30.00). The company earned $0.14 million during the quarter, compared to the consensus estimate of $0.12 million.

When did Motus GI's stock split?

Shares of Motus GI reverse split on Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

When did Motus GI IPO?

Motus GI (MOTS) raised $21 million in an initial public offering (IPO) on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray acted as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

How do I buy shares of Motus GI?

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Motus GI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Acasti Pharma (ACST) and Pfizer (PFE).

Company Calendar

• Last Earnings: 11/12/2021
• Today: 9/01/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MOTS
• CIK: 1686850
• Web: www.motusgi.com
• Phone: (954) 541-8000
• Fax: 954-541-8265
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $319 thousand
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.74 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,769,000
• Free Float: 5,749,000
• Market Cap: $1 thousand
• Optionable: Not Optionable
• Beta: 1.01